Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
0.6419
-0.0111 (-1.70%)
Aug 28, 2026, 4:00 PM EDT - Market closed

Standard BioTools Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
270.03120.86166.7351.781.3128.45
Short-Term Investments
206.6966.71126.1563.1984.48-
Cash & Short-Term Investments
476.72187.58292.87114.9165.7828.45
Cash Growth
101.08%-35.95%154.91%-30.70%482.70%-58.48%
Receivables
15.7513.4314.7419.6617.2818.32
Inventory
17.119.9820.7420.5321.4720.83
Prepaid Expenses
7.34.874.563.134.284.45
Restricted Cash
-----0.02
Other Current Assets
-228.4142.96---
Total Current Assets
516.87454.26375.88158.22208.8272.07
Property, Plant & Equipment
39.5546.0149.3454.8559.5465.15
Long-Term Investments
67.2825.7----
Goodwill
---106.32106.25106.38
Other Intangible Assets
---1.413.1829.18
Long-Term Deferred Tax Assets
0.2638.630.14-0.230.18
Other Long-Term Assets
3.263.15186.982.292.32.25
Total Assets
627.22567.75612.35323.07390.31275.21

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
9.555.415.059.247.9110.6
Accrued Expenses
23.9125.2416.7516.097.5213.59
Short-Term Debt
-----6.84
Current Portion of Long-Term Debt
---59.532.08-
Current Portion of Leases
5.625.494.814.323.683.05
Current Income Taxes Payable
3.03---1.44-
Current Unearned Revenue
12.024213.815.2214.4415.48
Other Current Liabilities
2.6730.1725.494.936.37-
Total Current Liabilities
56.8108.3165.9109.3343.4449.57
Long-Term Debt
0.30.30.33.9862.8164.21
Long-Term Leases
22.1725.0425.5930.3734.0837.55
Long-Term Unearned Revenue
6.047.7939.9214.2818.1824.08
Long-Term Deferred Tax Liabilities
0.820.811.080.841.064.33
Other Long-Term Liabilities
1.111.227.841.070.960.88
Total Liabilities
87.25143.46140.62159.87160.52180.62

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.410.40.40.080.080.08
Additional Paid-In Capital
1,7451,7321,702860.82847.01831.42
Retained Earnings
-1,160-1,261-1,186-1,001-926.1-736
Treasury Stock
-46.47-46.47-46.47-5.98-0.56-
Comprehensive Income & Other
1.18-1.491.23-2.22-1.9-0.91
Total Common Equity
539.97424.29471.72-148.05-81.4794.6
Shareholders' Equity
539.97424.29471.72163.2229.7994.6
Total Liabilities & Equity
627.22567.75612.35323.07390.31275.21

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
28.0930.8330.798.21102.66111.65
Net Cash (Debt)
448.63156.75262.1816.6963.13-83.2
Net Cash Growth
115.20%-40.21%1471.35%-73.57%--
Net Cash Per Share
1.160.410.740.210.81-1.10
Filing Date Shares Outstanding
392.58390.07378.99290.1279.0677.2
Total Common Shares Outstanding
392.12386.38377.5380.2379.4876.92
Working Capital
460.07345.96309.9948.89165.3722.5
Book Value Per Share
1.381.101.25-1.85-1.021.23
Tangible Book Value
539.97424.29471.72-255.77-200.9-40.97
Tangible Book Value Per Share
1.381.101.25-3.19-2.53-0.53
Buildings
---1.761.71-
Machinery
38.639.3743.2641.839.1238.09
Construction In Progress
0.560.96.032.331.614.55
Leasehold Improvements
13.7814.0513.7513.7912.2312.1
SEC Filings: 10-K · 10-Q